312 related articles for article (PubMed ID: 24890583)
1. Fidaxomicin inhibits Clostridium difficile toxin A-mediated enteritis in the mouse ileum.
Koon HW; Ho S; Hing TC; Cheng M; Chen X; Ichikawa Y; Kelly CP; Pothoulakis C
Antimicrob Agents Chemother; 2014 Aug; 58(8):4642-50. PubMed ID: 24890583
[TBL] [Abstract][Full Text] [Related]
2. Fidaxomicin and OP-1118 Inhibit Clostridium difficile Toxin A- and B-Mediated Inflammatory Responses via Inhibition of NF-κB Activity.
Koon HW; Wang J; Mussatto CC; Ortiz C; Lee EC; Tran DH; Chen X; Kelly CP; Pothoulakis C
Antimicrob Agents Chemother; 2018 Jan; 62(1):. PubMed ID: 29038278
[No Abstract] [Full Text] [Related]
3. The antimicrobial peptide cathelicidin modulates Clostridium difficile-associated colitis and toxin A-mediated enteritis in mice.
Hing TC; Ho S; Shih DQ; Ichikawa R; Cheng M; Chen J; Chen X; Law I; Najarian R; Kelly CP; Gallo RL; Targan SR; Pothoulakis C; Koon HW
Gut; 2013 Sep; 62(9):1295-305. PubMed ID: 22760006
[TBL] [Abstract][Full Text] [Related]
4. Intrarectal instillation of Clostridium difficile toxin A triggers colonic inflammation and tissue damage: development of a novel and efficient mouse model of Clostridium difficile toxin exposure.
Hirota SA; Iablokov V; Tulk SE; Schenck LP; Becker H; Nguyen J; Al Bashir S; Dingle TC; Laing A; Liu J; Li Y; Bolstad J; Mulvey GL; Armstrong GD; MacNaughton WK; Muruve DA; MacDonald JA; Beck PL
Infect Immun; 2012 Dec; 80(12):4474-84. PubMed ID: 23045481
[TBL] [Abstract][Full Text] [Related]
5. Human monoclonal antibodies against Clostridium difficile toxins A and B inhibit inflammatory and histologic responses to the toxins in human colon and peripheral blood monocytes.
Koon HW; Shih DQ; Hing TC; Yoo JH; Ho S; Chen X; Kelly CP; Targan SR; Pothoulakis C
Antimicrob Agents Chemother; 2013 Jul; 57(7):3214-23. PubMed ID: 23629713
[TBL] [Abstract][Full Text] [Related]
6. Fidaxomicin inhibits toxin production in Clostridium difficile.
Babakhani F; Bouillaut L; Sears P; Sims C; Gomez A; Sonenshein AL
J Antimicrob Chemother; 2013 Mar; 68(3):515-22. PubMed ID: 23208832
[TBL] [Abstract][Full Text] [Related]
7. The American Cockroach Peptide Periplanetasin-2 Blocks
Hong J; Zhang P; Yoon IN; Hwang JS; Kang JK; Kim H
J Microbiol Biotechnol; 2017 Apr; 27(4):694-700. PubMed ID: 28173695
[No Abstract] [Full Text] [Related]
8. Adenosine deaminase inhibition prevents Clostridium difficile toxin A-induced enteritis in mice.
de Araújo Junqueira AF; Dias AA; Vale ML; Spilborghs GM; Bossa AS; Lima BB; Carvalho AF; Guerrant RL; Ribeiro RA; Brito GA
Infect Immun; 2011 Feb; 79(2):653-62. PubMed ID: 21115723
[TBL] [Abstract][Full Text] [Related]
9. Vancomycin treatment's association with delayed intestinal tissue injury, clostridial overgrowth, and recurrence of Clostridium difficile infection in mice.
Warren CA; van Opstal EJ; Riggins MS; Li Y; Moore JH; Kolling GL; Guerrant RL; Hoffman PS
Antimicrob Agents Chemother; 2013 Feb; 57(2):689-96. PubMed ID: 23147742
[TBL] [Abstract][Full Text] [Related]
10. Contribution of adenosine A(2B) receptors in Clostridium difficile intoxication and infection.
Warren CA; Li Y; Calabrese GM; Freire RS; Zaja-Milatovic S; van Opstal E; Figler RA; Linden J; Guerrant RL
Infect Immun; 2012 Dec; 80(12):4463-73. PubMed ID: 23045479
[TBL] [Abstract][Full Text] [Related]
11. In vitro and in vivo antibacterial evaluation of cadazolid, a new antibiotic for treatment of Clostridium difficile infections.
Locher HH; Seiler P; Chen X; Schroeder S; Pfaff P; Enderlin M; Klenk A; Fournier E; Hubschwerlen C; Ritz D; Kelly CP; Keck W
Antimicrob Agents Chemother; 2014; 58(2):892-900. PubMed ID: 24277020
[TBL] [Abstract][Full Text] [Related]
12. Endogenous corticosteroids modulate Clostridium difficile toxin A-induced enteritis in rats.
Castagliuolo I; Karalis K; Valenick L; Pasha A; Nikulasson S; Wlk M; Pothoulakis C
Am J Physiol Gastrointest Liver Physiol; 2001 Apr; 280(4):G539-45. PubMed ID: 11254479
[TBL] [Abstract][Full Text] [Related]
13. High in vitro activity of fidaxomicin against Clostridium difficile isolates from a university teaching hospital in China.
Cheng JW; Yang QW; Xiao M; Yu SY; Zhou ML; Kudinha T; Kong F; Liao JW; Xu YC
J Microbiol Immunol Infect; 2018 Jun; 51(3):411-416. PubMed ID: 28693926
[TBL] [Abstract][Full Text] [Related]
14. Genetic deficiency in the chemokine receptor CCR1 protects against acute Clostridium difficile toxin A enteritis in mice.
Morteau O; Castagliuolo I; Mykoniatis A; Zacks J; Wlk M; Lu B; Pothoulakis C; Gerard NP; Gerard C
Gastroenterology; 2002 Mar; 122(3):725-33. PubMed ID: 11875005
[TBL] [Abstract][Full Text] [Related]
15. Saccharomyces boulardii protease inhibits Clostridium difficile toxin A effects in the rat ileum.
Castagliuolo I; LaMont JT; Nikulasson ST; Pothoulakis C
Infect Immun; 1996 Dec; 64(12):5225-32. PubMed ID: 8945570
[TBL] [Abstract][Full Text] [Related]
16. Comparison of the in vitro antibacterial activity of Ramizol, fidaxomicin, vancomycin, and metronidazole against 100 clinical isolates of Clostridium difficile by broth microdilution.
Wolfe C; Pagano P; Pillar CM; Shinabarger DL; Boulos RA
Diagn Microbiol Infect Dis; 2018 Nov; 92(3):250-252. PubMed ID: 30042035
[TBL] [Abstract][Full Text] [Related]
17. Saccharomyces boulardii protease inhibits the effects of Clostridium difficile toxins A and B in human colonic mucosa.
Castagliuolo I; Riegler MF; Valenick L; LaMont JT; Pothoulakis C
Infect Immun; 1999 Jan; 67(1):302-7. PubMed ID: 9864230
[TBL] [Abstract][Full Text] [Related]
18. Therapeutic Mechanism of Macrophage Inflammatory Protein 1 α Neutralizing Antibody (CCL3) in Clostridium difficile Infection in Mice.
Wang J; Ortiz C; Fontenot L; Mukhopadhyay R; Xie Y; Chen X; Feng H; Pothoulakis C; Koon HW
J Infect Dis; 2020 Apr; 221(10):1623-1635. PubMed ID: 31793629
[TBL] [Abstract][Full Text] [Related]
19. Fidaxomicin preserves the intestinal microbiome during and after treatment of Clostridium difficile infection (CDI) and reduces both toxin reexpression and recurrence of CDI.
Louie TJ; Cannon K; Byrne B; Emery J; Ward L; Eyben M; Krulicki W
Clin Infect Dis; 2012 Aug; 55 Suppl 2(Suppl 2):S132-42. PubMed ID: 22752862
[TBL] [Abstract][Full Text] [Related]
20. Essential involvement of IFN-gamma in Clostridium difficile toxin A-induced enteritis.
Ishida Y; Maegawa T; Kondo T; Kimura A; Iwakura Y; Nakamura S; Mukaida N
J Immunol; 2004 Mar; 172(5):3018-25. PubMed ID: 14978106
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
